三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

在线观看911精品国产| 熟妇乱在线观看| 小泽玛丽亚电影在线观看| 在线a人片免费观看国产| 久久99热精品免费观看| gay黄网在线观看黄网| 东京热不卡一区二区视频| 精品精品国产日韩26u| 亚洲精品熟女国产| 最新国语自产精品视频在| 精品一区二区成人码动漫| 国产青娱乐在线观看97| 久久国模国产亚洲av久| 36D亚洲精品| 欧美日韩中文字幕在线观看| 亚洲av手机在线观看。| 国产成人精品短视频一区| 天天操鸡巴视频| 亚洲女人天堂a在线播放| 鲁大师影院一区二区三区 | 欧美不卡一区二区三区四| 精品人妻少妇嫩草av无码专区| 成片免费观看视频在线网| 国产精品无码我AV在线| 韩国日本欧美一区二区视频| 免费看午夜福利在线观看| 福利自产拍福利一区二区| 久久亚洲精品9999p| 亚洲精品国产成人av…| 国产污污污在线观看网站| 国产好吊看视频在线观看| 成人在线免费视频你懂的| 在线日本视频一区二区三区| 精品国产男人的天堂久久| 在线小视频一区二区三区| 亚洲国产精品一区二区av| 在线 日韩 一区 二区| ae86老司机在线观看| 夜夜春无码视频| 国产精品亚洲lv粉色| 蜜乳av一区二区三区四|